Navigation Links
Midwest life science stocks sizzle in a tepid first quarter

The overall stock market performance for the first quarter of 2007 was not particularly exciting, although the ensuing three weeks represented a substantial improvement as the Dow Jones Industrials is poised to break through the 13,000 point barrier. So take the results, below, with a grain of salt.

The major life scien......

Full article >>> d> $53.08 <8%> $56.5 5. 3M (MMM) $76.43 $77.53 <1%> $56.1 6. Walgreen's (WAG) $45.89 $45.89 0% $45.9 7. Dow Chemical (DOW) $45.86 $40.00 +15% $44.0 8. Baxter International (BAX) $52.67
Full article >>> $17.66 $17.40 +1% $1.6 25. AllScripts Healthcare Solutions(MDRX) $26.81 $27.03 <1%> $1.5

Source: Yahoo Financial: www.yahoo.com, April 2, 2007

Now if you had bet on the Midwest Large Cap Life Science stocks during this tepid first quarter, you......

Full article >>> e retaining its specialty molecular diagnostics business, and its recent acquisition of cardiovascular company Kos Pharmaceuticals.

Baxter has showed increasing financial strength as the effects of the new management team and resulting reorganization a few years ago is giving credence to its new direction and focus. This included the announcement in the quarter of the spin-off of the for......

Full article >>> fe Science stocks!

See you soon!

Previous articles by Michael Rosen

Michael Rosen: A Midwest passage to India, Part II

Michael Rosen: Indian trade possibilities boggle the mind



Source:wistechnology.com By Michael Rosen 04/23/07


Related biology technology :

1. Midwest life science stocks kept sizzling in Q2
2. A Midwest passage to India, Part II
3. Midwest offers non-stop flight to North Carolina research park
4. A Midwest life-science odyssey comes full circle
5. Midwest hotter for healthcare investments
6. A Midwest small-cap, life-science surprise package
7. 2006: A mixed blessing for Midwest life science companies
8. Midwest gaining stature in nanotech research
9. Midwest colleges strong contenders for NIH funds
10. Japan on the rebound: Implications for Midwest
11. Investor links East Coast funds to Midwest tech
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the medical ... premium product recently added to the range of products distributed by Ampronix. ... ... ... Ampronix News ...
Breaking Biology News(10 mins):